HomeREGULATORY
REGULATORY

Global Headquarters Watching Japan, Keep Drug Prices for Patented Period: PhRMA, EFPIA
(May.19.2017)

EFPIA Japan Chairman Ole Moelskov Bech (left), PhRMA Japan-Chief Patrik Jonsson
The headquarters of global drug makers are keeping a close eye on whether the Japanese government will carry on its pro-innovation policies to maintain drug prices during the patent term, Japan chairmen of PhRMA and EFPIA stressed on May 18 ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 28.

News Calendar